Imatinib Terminated Phase 2 Trials for Scleroderma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01545427Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma